X

Biotechnology

Ocean Biomedical (OCEA) joins the Russell 2000 Index

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has been included in the Russell 2000 Index and the broad-market…

Ocean Biomedical granted US patent for bispecific cancer immunotherapy treatment

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Monday said its scientific co-founder Dr. Jack Elias has been granted a…

Ocean Biomedical extends patent rights for idiopathic pulmonary fibrosis discovery to Europe

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Friday revealed that its scientific co-founder Dr. Jack Elias has received notice…

Walgreens Boots Alliance (WBA) set to report Q3 results. What’s in the cards

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a leading retailer and wholesaler of health and wellness products, is scheduled to report…

Avid Bioservices Inc. (CDMO) Q4 2023 Earnings Call Transcript

Avid Bioservices Inc. (NASDAQ: CDMO) Q4 2023 earnings call dated Jun. 21, 2023 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President…

Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock…

Earnings Summary: A snapshot of Catalent’s Q3 2023 results

Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for…

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said…

Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a…

Ocean Biomedical (OCEA) set to join the Russell 2000 Index

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index,…

Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment

Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad…

Ocean Biomedical announces private placement of $25 mln convertible notes

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a…

Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7%

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite…

Corcept Therapeutics Incorporated (CORT) Q1 2023 Earnings Call Transcript

Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Atabak Mokari -- Chief Financial…

A snapshot of AmerisourceBergen’s Q2 2023 earnings results

Pharmaceutical solutions provider AmerisourceBergen Corporation (NYSE: ABC) reported higher revenues and adjusted earnings for the second quarter of 2023. Second-quarter…

VRTX Earnings: A snapshot of Vertex Pharmaceuticals’ Q1 2023 results

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported a decline in adjusted earnings for the first quarter, despite an…

Trxade Health Inc. (NASDAQ: MEDS) Q1 2023 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that operates as an integrated drug procurement and delivery platform.…

AMGN Earnings: Everything you need to know about Amgen’s Q1 results

Amgen Inc. (NASDAQ: AMGN) has reported lower revenues and adjusted earnings for the first quarter of 2023. The biotechnology firm…

Bristol-Myers Squibb (BMY) reports higher Q1 profit; revenue down 3%

Biotechnology company Bristol Myers Squibb (NYSE: BMY) said its first-quarter adjusted earnings increased modestly, despite a decline in revenues. Net…

MRK Earnings: Highlights of Merck’s Q1 2023 financial results

Pharma firm Merck & Co., Inc.  (NYSE: MRK) on Thursday reported lower earnings for the first quarter of 2023, due to…

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q1 2023 results

Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The…